BioPorto
Manufacturing · Denmark · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Tuborg Havnevej St 15, Hellerup, Region ...Phone Number
+45 45290000Website
www.bioporto.comRevenue
$5.6 MillionStock Symbol
BIOPORIndustry
About BioPorto
BioPorto Org Chart
Is BioPorto your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once BioPorto has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when BioPorto launches new products
Check if BioPorto has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on BioPorto recently announced quarterly report
Check out if BioPorto is spiking on competitors!
BioPorto, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if BioPorto had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at BioPorto
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
BioPorto is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioPorto is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioPorto.
BioPorto Tech Stack
A closer look at the technologies used by BioPorto
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioPorto
BioPorto specializes in developing diagnostic tools for acute kidney injury (AKI), with its flagship product being The NGAL Test, which enables early risk assessment in critically ill patients. The company also offers a range of NGAL biomarker products, including the FDA-cleared ProNephro AKI, aimed at pediatric AKI risk assessment. Their target cl... Read More